IL-10 serum level estimation in Iraqi colorectal and gastric cancer patients
DOI:
https://doi.org/10.32007/jfacmedbagdad.542750Keywords:
IL-10, Colorectal Cancer, Gastric Cancer.Abstract
Background:Gastrointestinal cancers (GITc) is a worldwide problem. In Iraq , Gastric cancer is the 9th commonest of the top cancers while colorectal cancers it is considered as the 7th commonest ten cancers.IL-10 appears to be more of a pro-tumor than anti-tumor properties in both colorectal and gastric cancers.
Objective:is to estimate the serum level of IL-10 in the Iraqi colorectal and gastric cancer Patientsand its relation to the progress of disease.
Patients and Methods:In ourstudy ,54 serum samples werecollected starting from the 1st of January to mid of March 2011, to investigate the IL-10 serum level by using ELISA kit. 38colorectal and gastric cancer patients (H.Pylori +ve) and 16 of healthy control group.
Results: The results showed that IL-10 serum levels of both GIT tumors were increased significantly (p<0.05) comparing with the healthy control group.
Conclusion:In conclusion, the high serum level of IL-10 in colorectal cancers is due to the pro-tumor properties of IL-10 while in gastric cancer while the association of IL-10 genotypes specifically the single nucleotide polymorphism of the IL-10 promoter region may be the source of its serum increasing level.
Downloads
Downloads
Published
Issue
Section
License
Permit others to copy and distribute the manuscript; to extract, revise, and create another derivative
works of or from the manuscript (e.g., a translation); to incorporate the manuscript into a
collective work; and to text or data mine the article, even for commercial purposes, provided that
the author(s) is/are credited; the article's modifications should not harm the author's honor or
reputation; and the article should not be altered in a way that would cause the author to lose them
reputation. The Creative Commons Attribution 4.0 International License (CC BY 4.0) has more
information.